News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Regulators

Regulatory Updates

FDA, EMA, PMDA, MHRA, and global regulatory coverage in one crawlable hub.

Open hub

Trials

Clinical Trial Watch

Phase readouts, trial design updates, enrollment milestones, and study results.

Open hub

Pipeline

Drug Pipeline

Regulatory pipeline signals, approvals, and market-moving development updates.

Open hub

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

daily refresh

Coverage

Latest indexed stories

9,192 stories indexed, page 115 of 154

🇫🇷Jan 1, 1970Investorsofinnovapartners.com

Featured signal

Johnson & Johnson to acquire Shockwave Medical — Sofinnova Partners

Publisher

Sofinnova Partners

Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.

Sofinnova PartnersOriginal publisher link

Canonical metadata stays public, while full text remains on the original site.

🇫🇷Jan 1, 1970Investorsofinnovapartners.com

GenSight Biologics Bolsters Regulatory Leadership in US and Europe with Two Senior Appointments — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.com

News 16 April, 2026 Freya Biosciences announces positive Phase 1 first-in-human data with FB301 for IVF-related embryo implantation failure

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.com

European Life Sciences Coalition launched to strengthen Europe’s life sciences investment ecosystem — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.com

News 16 March, 2026 Elevara Medicines doses first patient in Phase 2b START-SYNERGY trial of ELV001 in rheumatoid arthritis patients with incomplete response to TNFi

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.com

CEO spotlight: CinCor's Marc de Garidel — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.com

CEO spotlight: Thierry Abribat's third straight win — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.com

Boehringer Ingelheim licenses novel oral therapeutics program for immune diseases from Sitryx Therapeutics — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.com

Adapt or go extinct: Novameat unveils the ingredient that will save the global meat crisis — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.com

Abivax announces full year 2025 financial results and provides business updates — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.com

Sofinnova Partners exceeds target with €165M biotech acceleration fund, Europe’s largest, with strong Pharma support — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.com

Sofinnova Partners closes €650M ($750M) Capital XI, greatly exceeding initial target to back early-stage healthcare deals

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.com

News 10 March, 2026 May Health raises $11.7M to advance its novel technology to treat PCOS-related infertility

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.com

In Memory of Denis Lucquin — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.com

News 16 February, 2026 Artios strengthens leadership team to accelerate late-stage development of potential first-in-class oncology pipeline

Sofinnova PartnersOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.com

Sirnaomics Achieves 100% Complete Response in Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma | Sirnaomics

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.com

Sirnaomics Doses the First Patient in Phase I/II Clinical Study of RNAi Therapeutic STP705 for Treatment of Facial Squamous Cell Skin Cancer In Situ

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.com

Sirnaomics Receives IND Clearance from the Taiwan Ministry of Health and Welfare for Phase I Clinical Study of RNAi Therapeutic STP705 for Liver Cancer Treatment | Sirnaomics

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.com

Sirnaomics to Present the Latest Developments of Dual-Targeted RNAi Therapeutics based on its Proprietary GalAhead™ Program at the 4th Annual RNA Therapeutic: From Concept to Clinic Symposium

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.com

Sirnaomics Announces Publication of STP705 Clinical Study Results for Treatment of isSCC in the Peer-Reviewed Journal of Drugs in Dermatology

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.com

Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and GalAhead™ Programs at the TIDES USA 2022

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.com

Sirnaomics Doses First Subject in Phase I Clinical Trial of STP707 for the Treatment of Liver Fibrosis in Primary Sclerosing Cholangitis | Sirnaomics

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.com

Sirnaomics Announces Interim Data from Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma | Sirnaomics

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.com

Sirnaomics Receives Safe to Proceed Letter for U.S. FDA Investigational New Drug Application for Systemic RNAi Therapeutic STP707 in Primary Sclerosing Cholangitis (PSC) | Sirnaomics

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.com

Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP707 Delivered Systemically for the Treatment of Solid Tumors | Sirnaomics

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.com

Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP705 in Adults Undergoing Abdominoplasty for Medical Cosmetology Treatment | Sirnaomics

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysingulargenomics.com

Beth Israel Deaconess Medical Center Named a G4X Center of Excellence

Singular GenomicsOriginal source

🇺🇸Jan 1, 1970Industrysingulargenomics.com

John Stark Named CEO of Singular Genomics | Spatial Platform Leadership

Singular GenomicsOriginal source

🇺🇸Jan 1, 1970Industrysingulargenomics.com

Singular Genomics Launches G4X™ Spatial Research Challenge with Award of Spatial Multiomics Study up to 1,000-Samples March 26, 2026

Singular GenomicsOriginal source

🇺🇸Jan 1, 1970Industrysingulargenomics.com

Singular Genomics at AGBT 2026: Population-Scale Spatial Takes Center Stage G4X Launch, SPOT-Met Initiative February 25, 2026

Singular GenomicsOriginal source

🇺🇸Jan 1, 1970Industrysingulargenomics.com

Singular Genomics Completes Acquisition by Deerfield Management

Singular GenomicsOriginal source

🇺🇸Jan 1, 1970Industrysingulargenomics.com

Singular Genomics and Vanderbilt University Medical Center Launch Spatial Multiomics Center of Excellence

Singular GenomicsOriginal source

🇺🇸Jan 1, 1970Industrysingulargenomics.com

Singular Genomics Launches the G4X Platform for High-Throughput In Situ Multiomics

Singular GenomicsOriginal source

🇺🇸Jan 1, 1970Industrysingulargenomics.com

G4X Launch Milestones and 3D Spatial Multiomics at AGBT 2025

Singular GenomicsOriginal source

🇩🇪Jan 1, 1970Devicessiemens-healthineers.com

Building bridges between humans and medical technology

Siemens HealthineersOriginal source

🇩🇪Jan 1, 1970Devicessiemens-healthineers.com

Prostate cancer: Facts, diagnosis, and treatment

Siemens HealthineersOriginal source

🇩🇪Jan 1, 1970Devicessiemens-healthineers.com

Healthcare Perspectives podcast

Siemens HealthineersOriginal source

🇩🇪Jan 1, 1970Devicessiemens-healthineers.com

Modeling the human liver

Siemens HealthineersOriginal source

🇩🇪Jan 1, 1970Devicessiemens-healthineers.com

Liver cancer: From diagnosis to personalized treatment

Siemens HealthineersOriginal source

🇩🇪Jan 1, 1970Devicessiemens-healthineers.com

Medical assistance robots: The robotics innovator

Siemens HealthineersOriginal source

🇩🇪Jan 1, 1970Devicessiemens-healthineers.com

Digital Twin What is a digital patient twin?

Siemens HealthineersOriginal source

🇩🇪Jan 1, 1970Devicessiemens-healthineers.com

The code guardian

Siemens HealthineersOriginal source

🇨🇦Jan 1, 1970Researchsickkids.ca

The Perspective: Finding answers through clinical research

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.ca

SickKids researchers awarded renewed Canada Research Chairs and NFRF funding

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.ca

SickKids-led research uncovers new genetic cause of Crohn’s disease

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.ca

SickKids Child Health Policy Accelerator welcomes the introduction of the Safe Social Media Act

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.ca

Protein map offers clues to understanding gene changes linked to cancer and ALS

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.ca

Powering precision: How next-gen computing is fueling scientific discovery at SickKids

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.ca

Coming to SickKids? Plan ahead during the FIFA World Cup

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.ca

Non-coding gene linked to core social and behavioural traits in Autism, major SickKids-led study finds

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.ca

‘A monumental example of translational science’

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.ca

John Rubinstein elected to prestigious Royal Society

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.ca

Everything families need to know about surgery – in one place

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.ca

AI model helps kids get the right medication sooner

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.ca

SickKids named world’s best children’s hospital

SickKids (Hospital for Sick Children) NewsOriginal source

🇯🇵Jan 1, 1970Industryshionogi.com

Engagement with shareholders and investors

Shionogi (IR News)Original source

🇯🇵Jan 1, 1970Industryshionogi.com

Supply socially responsible products and services

Shionogi (IR News)Original source

🇯🇵Jan 1, 1970Industryshionogi.com

Social contribution activities

Shionogi (IR News)Original source

🇯🇵Jan 1, 1970Industryshionogi.com

Sustainability-related Initiatives and memberships

Shionogi (IR News)Original source

🇯🇵Jan 1, 1970Industryshionogi.com

Promote proper use of medicines

Shionogi (IR News)Original source